Kevin Balthaser's Net Worth

-$31.8 Thousand

Estimate Recalculated May 3, 2024 03:27PM EST

Who is Kevin Balthaser?

Kevin Balthaser does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Aclaris Therapeutics, Inc..

SEC CIK

Kevin Balthaser's CIK is 0001957554

Past Insider Trading and Trends

2023 was Kevin Balthaser's most active year for acquiring shares with 8 total transactions. Kevin Balthaser's most active month to acquire stocks was the month of January. 2023 was Kevin Balthaser's most active year for disposing of shares, totalling 8 transactions. Kevin Balthaser's most active month to dispose stocks was the month of February. 2023 saw Kevin Balthaser paying a total of $74,971.00 for 151,940 shares, this is the most they've acquired in one year. In 2023 Kevin Balthaser cashed out on 9,629 shares for a total of $25,830.02, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Aclaris Therapeutics, Inc. (ACRS) Snapshot price: $1.12

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+17.42%
3.56K
$1.24
-$1,757.08
23.98K
Mar 1 - Mar 2
Form 4
—
0
—
—
0
Feb 1
Form 4
+32.11%
4.96K
$1.05
-$2,662.80
20.43K
Jan 1
Form 4
+158.93%
9.49K
$7.90
$74,971.00
15.46K
Sep 6
Form 4
+13.60%
715
$7.90
-$2,251.50
5.97K
Sep 1
Form 4
+650.86%
4.56K
$12.45
-$23,578.52
5.26K
Mar 1 - Mar 3
Form 4
—
0
—
—
0
Feb 1
Form 3
—
0
—
—
0
No matching records found